Phase II Study of KHK6188 (A Placebo-controlled, Double Blind, Crossover Study of KHK6188 in Postherpetic Neuralgia)
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2017
At a glance
- Drugs KHK 6188 (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2013 Planned End Date changed from 1 Mar 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 21 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.